These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34602320)

  • 1. A Novel Model and Infrastructure for Clinical Outcomes Data Collection and Their Systematic Evaluation for UK Patients Receiving Proton Beam Therapy.
    Hwang E; Burnet NG; Crellin AM; Ahern V; Thwaites DI; Gaito S; Chang YC; Smith E
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):11-18. PubMed ID: 34602320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group.
    Gaito S; Hwang EJ; France A; Aznar MC; Burnet N; Crellin A; Holtzman AL; Indelicato DJ; Timmerman B; Whitfield GA; Smith E
    Clin Oncol (R Coll Radiol); 2023 May; 35(5):283-291. PubMed ID: 36804292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
    Hwang E; Gaito S; France A; Crellin AM; Thwaites DI; Ahern V; Indelicato D; Timmermann B; Smith E
    Clin Oncol (R Coll Radiol); 2023 May; 35(5):292-300. PubMed ID: 36813694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
    Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
    Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Promise of Proton Beam Therapy for Oesophageal Cancer: A Systematic Review of Dosimetric and Clinical Outcomes.
    Nicholas O; Prosser S; Mortensen HR; Radhakrishna G; Hawkins MA; Gwynne SH
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):e339-e358. PubMed ID: 33931290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled Trials.
    Hudson EM; Slevin F; Biscombe K; Brown SR; Haviland JS; Murray L; Kirby AM; Thomson DJ; Sebag-Montefiore D; Hall E
    Clin Oncol (R Coll Radiol); 2024 Feb; 36(2):70-79. PubMed ID: 38042671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
    Dutz A; Lühr A; Troost EGC; Agolli L; Bütof R; Valentini C; Baumann M; Vermeren X; Geismar D; Timmermann B; Krause M; Löck S
    Radiother Oncol; 2021 Jul; 160():69-77. PubMed ID: 33872640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton beam therapy in rectal cancer: A systematic review and meta-analysis.
    Fok M; Toh S; Easow J; Fowler H; Clifford R; Parsons J; Vimalachandran D
    Surg Oncol; 2021 Sep; 38():101638. PubMed ID: 34340196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intelligent ePR system for evidence-based research in radiotherapy: proton therapy for prostate cancer.
    Le AH; Liu B; Schulte R; Huang HK
    Int J Comput Assist Radiol Surg; 2011 Nov; 6(6):769-84. PubMed ID: 21409498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.
    Ojerholm E; Kirk ML; Thompson RF; Zhai H; Metz JM; Both S; Ben-Josef E; Plastaras JP
    Acta Oncol; 2015; 54(8):1209-17. PubMed ID: 25734796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Dental Toxicities After Proton Chemoradiation for Rhabdomyosarcoma: A Pediatric Case Report.
    Foster-Thomas E; Aznar M; Indelicato D; Pan S; Hwang E; Sitch P; Horner K; Smith E; Gaito S
    Int J Part Ther; 2023; 9(3):50-57. PubMed ID: 36721482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
    Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
    Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of proton beam therapy pedagogy within the UK's pre-registration radiotherapy and oncology higher education setting.
    Lykowski T; Jhagra R; Bennett C
    Radiography (Lond); 2022 May; 28(2):267-275. PubMed ID: 35190248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
    Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proton versus photon treatment planning for the Medicare Medical Treatment Overseas Program: The Royal Adelaide Hospital experience.
    Hu Y; Dalfsen R; Penfold SN; Gorayski P; Tee HC; Penniment M; Le H
    J Med Imaging Radiat Oncol; 2020 Oct; 64(5):682-688. PubMed ID: 32243727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating patient reported outcomes and experiences in a novel proton beam clinic - challenges, activities, and outcomes of the ProtonCare project.
    Sjövall K; Langegård U; Fransson P; Nevo-Ohlsson E; Kristensen I; Ahlberg K; Johansson B
    BMC Cancer; 2023 Feb; 23(1):132. PubMed ID: 36759789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy.
    Ofuya M; McParland L; Murray L; Brown S; Sebag-Montefiore D; Hall E
    Clin Transl Radiat Oncol; 2019 Nov; 19():17-26. PubMed ID: 31372521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.